Kaléo Donates Thousands of Auto-injectors to Hurricane Relief Efforts
Friday, September 1, 2017
Kaléo, a privately-held pharmaceutical company, has donated 20,000 AUVI-Q®(epinephrine injection, USP) Auto-injectors and 5,000 EVZIO® (naloxone HCl injection) Auto-injectors to medical aid organization Direct Relief in support of Hurricane Harvey relief efforts in Texas, Louisiana and other affected states.
“Tens of thousands of people have had to flee their homes with little more than the clothes on their backs,” said Spencer Williamson, President and CEO of kaléo. “We are proud to work with Direct Relief to ensure that our epinephrine and naloxone products are available to patients in need.”
“We are deeply appreciative for the donation by kaléo and are pleased to work with them to help support the medical needs of the victims of Hurricane Harvey along the Gulf Coast,” said Pat Bacuros, Direct Relief’s Director of Philanthropic Investment. “As the only non-profit medical aid organization to obtain Verified-Accredited Wholesale Distributor status from the National Association of Boards of Pharmacy, Direct Relief is a natural partner for kaléo to get these potentially life-saving medications to those in the greatest need.”
AUVI-Q (0.15 mg and 0.3 mg) is a prescription medicine used to treat life-threatening allergic reactions, including anaphylaxis, in people who are at risk for or have a history of serious allergic reactions. EVZIO was the first naloxone product specifically designed, approved and labeled for the emergency treatment of opioid overdose by individuals without medical training. The products are both FDA-approved and have innovative features such as voice instructions that help guide users with step-by-step instructions through the delivery process of the medications. The products also feature an automatic retractable needle system that injects the medication and retracts the needle back into the device within seconds.
“One out of every 13 children in the U.S. has at least one food allergy,” said Dr. James R. Baker, Jr., CEO of Food Allergy Research and Education (FARE). “Therefore, it is likely that there are many children with life-threatening allergies among the flood victims. We are pleased to see efforts to ensure replacement epinephrine to patients who may have lost their auto-injectors in this emergency.”
“I commend Direct Relief and kaléo for taking bold action to help victims of Hurricane Harvey obtain the medicines they need in this crisis,” said Mark Kinzly, Co-founder of the Texas Overdose Naloxone Initiative. “The opioid overdose crisis will not recede during this natural disaster. Having access to naloxone in the affected areas will help save lives.”
“With the devastating situation in Texas and Louisiana due to Hurricane Harvey, and many families there affected by food allergies and life-threatening anaphylaxis, it’s imperative for individuals to have immediate access to potentially life-saving medications, including epinephrine,” said Eleanor Garrow-Holding, President and CEO of the Food Allergy & Anaphylaxis Connection Team (FAACT). “Thank you to our partner, kaléo, and to Direct Relief, for providing these auto-injectors for those most in need.”